Tetrabuthylammonium

Tetrabuthylammonium

SCHEMBL3702709

CCCC[N+](CCCC)(CCCC)CCCC.CCCC[N+](CCCC)(CCCC)CCCC.O=C([O-])c1ccccc1-c1ccccc1C(=O)[O-]

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.44
CYP3A4 P08684 2/20 0.44
TP53 P04637 1/20 0.44
MAPK1 P28482 1/20 0.44
PTPN11 Q06124 2/20 0.43
ALDH1A1 P00352 3/20 0.42
LMNA P02545 2/20 0.42
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
HTT P42858 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
CNR2 P34972 2/20 0.41
CES2 O00748 2/20 0.40
CES1 P23141 2/20 0.40
HPGD P15428 2/20 0.40
SLC22A1 O15245 1/20 0.40
KDM4E B2RXH2 2/20 0.39
NAAA Q02083 1/20 0.39
NR1I2 O75469 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tetrabuthylammonium SCHEMBL106854 0.91 TSHR (0.47) TSHRCYP3A4TP53MAPK1ALDH1A1
Tetrabuthylammonium SCHEMBL107740 0.85 KDM4E (0.59) TSHRCYP3A4TP53MAPK1ALDH1A1
Tetrabuthylammonium SCHEMBL106856 0.85 ALDH1A1 (0.47) TSHRCYP3A4TP53MAPK1PTPN11
Tetrabuthylammonium SCHEMBL28459959 0.85 TSHR (0.42) TSHRCYP3A4TP53MAPK1ALDH1A1
Tetrabuthylammonium SCHEMBL28257379 0.85 PTPN11 (0.57) TSHRCYP3A4TP53MAPK1PTPN11
Tetrabuthylammonium SCHEMBL23522665 0.84 HDAC3 (0.49) TSHRCYP3A4TP53MAPK1ALDH1A1
Tetrabuthylammonium SCHEMBL1684318 0.84 HPGD (0.51) TSHRCYP3A4TP53MAPK1ALDH1A1
Tetrabuthylammonium SCHEMBL28624852 0.84 CYP3A4 (0.50) TSHRCYP3A4TP53MAPK1ALDH1A1
Tetrabuthylammonium SCHEMBL7188512 0.84 MAPT (0.42) TSHRCYP3A4TP53MAPK1ALDH1A1
Tetrabuthylammonium SCHEMBL29420045 0.84 ALDH1A1 (0.52) TSHRCYP3A4TP53MAPK1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220002466-A1 POLYMERS IMPERIAL COLLEGE INNOVATIONS LIMITED (GB) 2022-01-06 US claimed
WO-2020065295-A1 POLYMERS IMPERIAL COLLEGE OF SCIENCE, TECHNOLOGY AND MEDICINE (GB) 2020-04-02 WO claimed
EP-0564727-B1 Process for the preparation of aryl polycarbonates in the presence of bioxyanion catalysts COUNCIL SCIENT IND RES (IN) 1997-08-13 EP claimed
EP-0564727-A1 Process for the preparation of aryl polycarbonates in the presence of bioxyanion catalysts Council of Scientific and Industrial Research (IN) 1993-10-13 EP claimed
US-4906713-A \"Acrylic\" ladder polymers E. I. DU PONT DE NEMOURS AND COMPANY (US) 1990-03-06 US claimed
US-12636247-B2 Cosmetic SHIN-ETSU CHEMICAL CO., LTD. (JP) 2026-05-26 US disclosed
EP-4154970-B1 USE OF A DIBLOCK COPOLYMER AS EMULSIFIER SHINETSU CHEMICAL CO (JP) 2026-04-08 EP disclosed
US-12030902-B2 Polymer crosslinking agent, and high molecular weight polymer and composition using same SHIN-ETSU CHEMICAL CO., LTD. (JP) 2024-07-09 US disclosed
EP-3766908-B1 POLYMER CROSSLINKING AGENT, AND HIGH MOLECULAR WEIGHT POLYMER AND COMPOSITION USING SAME SHINETSU CHEMICAL CO (JP) 2024-03-13 EP disclosed
CN-115551475-B Cosmetic product 信越化学工业株式会社 2024-01-05 CN disclosed
US-20230263720-A1 COSMETIC SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-08-24 US disclosed
US-20230193138-A1 EMULSIFIER AND EMULSION COMPOSITION CONTAINING SAME SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-06-22 US disclosed
US-5288838-A Preparation of polycarbonates with bioxyanion catalyst COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 1994-02-22 US disclosed
EP-0564727-A1 Process for the preparation of aryl polycarbonates in the presence of bioxyanion catalysts Council of Scientific and Industrial Research (IN) 1993-10-13 EP disclosed
US-5021524-A Organo-silicon, genmanium and tin compounds; acrylic or maleimide monomers E. I. DU PONT DE NEMOURS AND COMPANY (US) 1991-06-04 US disclosed
US-5019634-A Group transfer living polymer grafted to an initiator support E. I. DU PONT DE NEMOURS AND COMPANY (US) 1991-05-28 US disclosed
US-4978723-A Phosphonate-capped polymers E. I. DU PONT DE NEMOURS AND COMPANY (US) 1990-12-18 US disclosed
US-4943648-A REACTION PRODUCT OF SILYL KETENE ACETAL AND UNSATURTED COMPOUND E. I. DU PONT DE NEMOURS AND COMPANY (US) 1990-07-24 US disclosed
US-4940760-A ATTACHED TO SOLID SUPPORT THAT IS INSOLUBLE IN REACTION MEDIUM; ORGANO-SILICON,-GERMANIUM OR-TIN COMPOUND E. I. DU PONT DE NEMOURS AND COMPANY (US) 1990-07-10 US disclosed
US-4939211-A Phosphonate-capped polymers E. I. DU PONT DE NEMOURS AND COMPANY (US) 1990-07-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230193138-A1 EMULSIFIER AND EMULSION COMPOSITION CONTAINING SAME APOB, F12, H1-0 TSHR 3000/4885CYP3A4 2678/4885TP53 1434/4885
US-12030902-B2 Polymer crosslinking agent, and high molecular weight polymer and composition using same SMCHD1, MUS81, MGLL TSHR 4056/4885CYP3A4 3108/4885TP53 3891/4885
US-20230263720-A1 COSMETIC ALG1, ALG3, CUTA TSHR 2924/4885CYP3A4 2191/4885TP53 3878/4885
US-12636247-B2 Cosmetic MSR1, TLR3, LOXL1 TSHR 1774/4885CYP3A4 4341/4885TP53 2268/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.